Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0000947871-26-000784

Director bought 625,000 shares at $16.00 ($10,000,000)

  • Director acquired 2,089,279 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ORBIMED ADVISORS LLC Director 2026-08-10 Conversion +1,039,996 1,039,996 I
ORBIMED ADVISORS LLC Director 2026-08-10 Conversion +1,049,283 2,089,279 I
ORBIMED ADVISORS LLC Director 2026-08-10 Purchase +625,000 $16.00 $10,000,000 2,714,279 I
Derivatives
ORBIMED ADVISORS LLC Director 2026-08-10 Conversion · Series A Preferred Stock −1,039,996 0 I
ORBIMED ADVISORS LLC Director 2026-08-10 Conversion · Series B Preferred Stock −1,049,283 0 I
Open-market purchases · 625,000 sh · avg $16.00 · $10,000,000
Loading xslF345X06/ownership.xml…